ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning (2019)
Snyder, James; Wells, Michael; Poisson, Laila; Kalkanis, Steven; Noushmehr, Houtan ; Robin, Adam
Fonte: Neuro-oncology. Nome do evento: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Assuntos: ENSAIO CLÍNICO, MENINGIOMA, GLÂNDULA PITUITÁRIA, NEOPLASIAS CEREBRAIS, ASTROCITOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SNYDER, James et al. Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.558. Acesso em: 04 dez. 2025. , 2019
APA
Snyder, J., Wells, M., Poisson, L., Kalkanis, S., Noushmehr, H., & Robin, A. (2019). Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.558
NLM
Snyder J, Wells M, Poisson L, Kalkanis S, Noushmehr H, Robin A. Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning [Internet]. Neuro-oncology. 2019 ; 21 vi133.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1093/neuonc/noz175.558
Vancouver
Snyder J, Wells M, Poisson L, Kalkanis S, Noushmehr H, Robin A. Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning [Internet]. Neuro-oncology. 2019 ; 21 vi133.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1093/neuonc/noz175.558
Artigo de periodico
DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management (2019)
Nassiri, Farshad; Mamatjan, Yasin; Suppiah, Suganth; Badhiwala, Jetan H.; Mansouri, Sheila; Karimi, Shirin; Saarela, Olli; Poisson, Laila; Gepfner-Tuma, Irina; Schittenhelm, Jens; Noushmehr, Houtan
Fonte: Neuro-Oncology. Unidade: FMRP
Assuntos: MENINGIOMA, METILAÇÃO, DNA, RADIOTERAPIA, ESTUDOS DE VALIDAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASSIRI, Farshad et al. DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management. Neuro-Oncology, v. 21, n. 7, p. 901-910, 2019Tradução . . Disponível em: https://doi.org/10.1093/neuonc/noz061. Acesso em: 04 dez. 2025.
APA
Nassiri, F., Mamatjan, Y., Suppiah, S., Badhiwala, J. H., Mansouri, S., Karimi, S., et al. (2019). DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management. Neuro-Oncology, 21( 7), 901-910. doi:10.1093/neuonc/noz061
NLM
Nassiri F, Mamatjan Y, Suppiah S, Badhiwala JH, Mansouri S, Karimi S, Saarela O, Poisson L, Gepfner-Tuma I, Schittenhelm J, Noushmehr H. DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management [Internet]. Neuro-Oncology. 2019 ; 21( 7): 901-910.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1093/neuonc/noz061
Vancouver
Nassiri F, Mamatjan Y, Suppiah S, Badhiwala JH, Mansouri S, Karimi S, Saarela O, Poisson L, Gepfner-Tuma I, Schittenhelm J, Noushmehr H. DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management [Internet]. Neuro-Oncology. 2019 ; 21( 7): 901-910.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1093/neuonc/noz061
Trabalho de evento-resumo periodico
DNA methylation abnormalities in non-promoter regulatory regions are associated with invasive behavior in pituitary tumors (2019)
Mosella, Maritza Queiroz Salas ; Sabedot, Thais Sarraf; Malta, Tathiane Maistro; Rock, J.; Felicella, M.; Aho, T.; Noushmehr, Houtan ; Castro, A. V.
Fonte: Neuro-Oncology. Nome do evento: Annual Meeting European Association of Neuro-Oncology - EANO. Unidade: FMRP
Assuntos: GLÂNDULA PITUITÁRIA, TUMOR CARCINOIDE, METILAÇÃO DE DNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOSELLA, Maritza Queiroz Salas et al. DNA methylation abnormalities in non-promoter regulatory regions are associated with invasive behavior in pituitary tumors. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/noz126.236. Acesso em: 04 dez. 2025. , 2019
APA
Mosella, M. Q. S., Sabedot, T. S., Malta, T. M., Rock, J., Felicella, M., Aho, T., et al. (2019). DNA methylation abnormalities in non-promoter regulatory regions are associated with invasive behavior in pituitary tumors. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noz126.236
NLM
Mosella MQS, Sabedot TS, Malta TM, Rock J, Felicella M, Aho T, Noushmehr H, Castro AV. DNA methylation abnormalities in non-promoter regulatory regions are associated with invasive behavior in pituitary tumors [Internet]. Neuro-Oncology. 2019 ; 21 iii65.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1093/neuonc/noz126.236
Vancouver
Mosella MQS, Sabedot TS, Malta TM, Rock J, Felicella M, Aho T, Noushmehr H, Castro AV. DNA methylation abnormalities in non-promoter regulatory regions are associated with invasive behavior in pituitary tumors [Internet]. Neuro-Oncology. 2019 ; 21 iii65.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1093/neuonc/noz126.236
Trabalho de evento-resumo periodico
Modified chromatin histone marks at noncoding elements are associated with aggressive meningioma subtype (2019)
Malta, T.; Sabedot, T.; Lee, I.; Wells, M.; Castro, A.; Noushmehr, Houtan
Fonte: Neuro-Oncology. Nome do evento: Annual Meeting European Association of Neuro-Oncology - EANO. Unidade: FMRP
Assuntos: NEOPLASIAS DO SISTEMA NERVOSO, MENINGIOMA, CROMATINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTA, T. et al. Modified chromatin histone marks at noncoding elements are associated with aggressive meningioma subtype. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/noz126.058. Acesso em: 04 dez. 2025. , 2019
APA
Malta, T., Sabedot, T., Lee, I., Wells, M., Castro, A., & Noushmehr, H. (2019). Modified chromatin histone marks at noncoding elements are associated with aggressive meningioma subtype. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noz126.058
NLM
Malta T, Sabedot T, Lee I, Wells M, Castro A, Noushmehr H. Modified chromatin histone marks at noncoding elements are associated with aggressive meningioma subtype [Internet]. Neuro-Oncology. 2019 ; 21 iii7.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1093/neuonc/noz126.058
Vancouver
Malta T, Sabedot T, Lee I, Wells M, Castro A, Noushmehr H. Modified chromatin histone marks at noncoding elements are associated with aggressive meningioma subtype [Internet]. Neuro-Oncology. 2019 ; 21 iii7.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1093/neuonc/noz126.058
Trabalho de evento-resumo periodico
Active transcription start sites of meningioma samples associated with risk of recurrence (2019)
Malta, Tathiane; Sabedot, Thais Sarra; Carlotti Júnior, Carlos Gilberto ; Noushmehr, Houtan
Fonte: Neuro-oncology. Nome do evento: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Assuntos: TRANSCRIÇÃO GÊNICA, MENINGIOMA, NEOPLASIAS CEREBRAIS, EPIGÊNESE GENÉTICA, METILAÇÃO DE DNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTA, Tathiane et al. Active transcription start sites of meningioma samples associated with risk of recurrence. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.460. Acesso em: 04 dez. 2025. , 2019
APA
Malta, T., Sabedot, T. S., Carlotti Júnior, C. G., & Noushmehr, H. (2019). Active transcription start sites of meningioma samples associated with risk of recurrence. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.460
NLM
Malta T, Sabedot TS, Carlotti Júnior CG, Noushmehr H. Active transcription start sites of meningioma samples associated with risk of recurrence [Internet]. Neuro-oncology. 2019 ; 21 vi110.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1093/neuonc/noz175.460
Vancouver
Malta T, Sabedot TS, Carlotti Júnior CG, Noushmehr H. Active transcription start sites of meningioma samples associated with risk of recurrence [Internet]. Neuro-oncology. 2019 ; 21 vi110.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1093/neuonc/noz175.460
Trabalho de evento-resumo periodico
Gene expression signature associated with aggressive glioblastoma growth is enriched in chromatin modification and stemness transcriptional regulation programs (2019)
Berezovsky, Artem; Nuga, Oluwademilade; Meng, Yuling; Poisson, Laila; Noushmehr, Houtan ; Carvalho, Ana de
Fonte: Neuro-oncology. Nome do evento: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Assuntos: NEOPLASIAS CEREBRAIS, EXPRESSÃO GÊNICA, REGULAÇÃO GÊNICA, LINHAGEM CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BEREZOVSKY, Artem et al. Gene expression signature associated with aggressive glioblastoma growth is enriched in chromatin modification and stemness transcriptional regulation programs. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.457. Acesso em: 04 dez. 2025. , 2019
APA
Berezovsky, A., Nuga, O., Meng, Y., Poisson, L., Noushmehr, H., & Carvalho, A. de. (2019). Gene expression signature associated with aggressive glioblastoma growth is enriched in chromatin modification and stemness transcriptional regulation programs. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.457
NLM
Berezovsky A, Nuga O, Meng Y, Poisson L, Noushmehr H, Carvalho A de. Gene expression signature associated with aggressive glioblastoma growth is enriched in chromatin modification and stemness transcriptional regulation programs [Internet]. Neuro-oncology. 2019 ; 21 vi109.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1093/neuonc/noz175.457
Vancouver
Berezovsky A, Nuga O, Meng Y, Poisson L, Noushmehr H, Carvalho A de. Gene expression signature associated with aggressive glioblastoma growth is enriched in chromatin modification and stemness transcriptional regulation programs [Internet]. Neuro-oncology. 2019 ; 21 vi109.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1093/neuonc/noz175.457
Artigo de periodico
Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women (2019)
Lawrenson, Kate; Song, Fengju; Hazelett, Dennis J.; Kar, Siddhartha P.; Tyrer, Jonathan; Phelan, Catherine M.; Corona, Rosario I.; Rodríguez-Malavé, Norma I.; Seo, Ji-Hei; Adler, Emily; Noushmehr, Houtan
Fonte: Gynecologic Oncology. Unidade: FMRP
Assuntos: GENÉTICA DE POPULAÇÕES, ANCESTRAIS, GENOMAS, NEOPLASIAS OVARIANAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LAWRENSON, Kate et al. Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women. Gynecologic Oncology, v. 153, n. 2, p. 343-355, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.ygyno.2019.02.023. Acesso em: 04 dez. 2025.
APA
Lawrenson, K., Song, F., Hazelett, D. J., Kar, S. P., Tyrer, J., Phelan, C. M., et al. (2019). Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women. Gynecologic Oncology, 153( 2), 343-355. doi:10.1016/j.ygyno.2019.02.023
NLM
Lawrenson K, Song F, Hazelett DJ, Kar SP, Tyrer J, Phelan CM, Corona RI, Rodríguez-Malavé NI, Seo J-H, Adler E, Noushmehr H. Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women [Internet]. Gynecologic Oncology. 2019 ; 153( 2): 343-355.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1016/j.ygyno.2019.02.023
Vancouver
Lawrenson K, Song F, Hazelett DJ, Kar SP, Tyrer J, Phelan CM, Corona RI, Rodríguez-Malavé NI, Seo J-H, Adler E, Noushmehr H. Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women [Internet]. Gynecologic Oncology. 2019 ; 153( 2): 343-355.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1016/j.ygyno.2019.02.023
Artigo de periodico
Clinical and research applications of a brain tumor tissue bank in the age of precision medicine (2019)
Snyder, James; Poisson, Laila M.; Noushmehr, Houtan ; Castro, Ana V.; Carvalho, Ana C. de; Robin, Adam; Mukherjee, Abir; Lee, Ian; Walbert, Tobias
Fonte: Personalized Medicine. Unidade: FMRP
Assuntos: NEOPLASIAS CEREBRAIS, GLIOMA, CÉREBRO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SNYDER, James et al. Clinical and research applications of a brain tumor tissue bank in the age of precision medicine. Personalized Medicine, v. 16, n. 2, p. 145-156, 2019Tradução . . Disponível em: https://doi.org/10.2217/pme-2018-0102. Acesso em: 04 dez. 2025.
APA
Snyder, J., Poisson, L. M., Noushmehr, H., Castro, A. V., Carvalho, A. C. de, Robin, A., et al. (2019). Clinical and research applications of a brain tumor tissue bank in the age of precision medicine. Personalized Medicine, 16( 2), 145-156. doi:10.2217/pme-2018-0102
NLM
Snyder J, Poisson LM, Noushmehr H, Castro AV, Carvalho AC de, Robin A, Mukherjee A, Lee I, Walbert T. Clinical and research applications of a brain tumor tissue bank in the age of precision medicine [Internet]. Personalized Medicine. 2019 ; 16( 2): 145-156.[citado 2025 dez. 04 ] Available from: https://doi.org/10.2217/pme-2018-0102
Vancouver
Snyder J, Poisson LM, Noushmehr H, Castro AV, Carvalho AC de, Robin A, Mukherjee A, Lee I, Walbert T. Clinical and research applications of a brain tumor tissue bank in the age of precision medicine [Internet]. Personalized Medicine. 2019 ; 16( 2): 145-156.[citado 2025 dez. 04 ] Available from: https://doi.org/10.2217/pme-2018-0102
Artigo de periodico
Molecular and translational advances in meningiomas (2019)
Suppiah, Suganth; Nassiri, Farshad; Bi, Wenya Linda; Dunn, Ian F.; Hanemann, Clemens Oliver; Horbinski, Craig M.; Hashizume, Rintaro; James, Charles David; Mawrin, Christian; Noushmehr, Houtan
Fonte: Neuro-oncology. Unidade: FMRP
Assuntos: GENÉTICA, LINHAGEM CELULAR, MENINGIOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SUPPIAH, Suganth et al. Molecular and translational advances in meningiomas. Neuro-oncology, v. 21, p. 4-17, 2019Tradução . . Disponível em: https://doi.org/10.1093/neuonc/noy178. Acesso em: 04 dez. 2025.
APA
Suppiah, S., Nassiri, F., Bi, W. L., Dunn, I. F., Hanemann, C. O., Horbinski, C. M., et al. (2019). Molecular and translational advances in meningiomas. Neuro-oncology, 21, 4-17. doi:10.1093/neuonc/noy178
NLM
Suppiah S, Nassiri F, Bi WL, Dunn IF, Hanemann CO, Horbinski CM, Hashizume R, James CD, Mawrin C, Noushmehr H. Molecular and translational advances in meningiomas [Internet]. Neuro-oncology. 2019 ; 21 4-17.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1093/neuonc/noy178
Vancouver
Suppiah S, Nassiri F, Bi WL, Dunn IF, Hanemann CO, Horbinski CM, Hashizume R, James CD, Mawrin C, Noushmehr H. Molecular and translational advances in meningiomas [Internet]. Neuro-oncology. 2019 ; 21 4-17.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1093/neuonc/noy178
Artigo de periodico
A transcriptome-wide association study of high-grade serous epithelial ovarian cancer identifies new susceptibility genes and splice variants (2019)
Gusev, Alexander; Lawrenson, Kate; Lin, Xianzhi; Lyra Júnior, Paulo C.; Kar, Siddhartha; Noushmehr, Houtan
Fonte: Nature Genetics. Unidade: FMRP
Assuntos: NEOPLASIAS OVARIANAS, SEQUENCIAMENTO GENÉTICO, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUSEV, Alexander et al. A transcriptome-wide association study of high-grade serous epithelial ovarian cancer identifies new susceptibility genes and splice variants. Nature Genetics, v. 51, n. 5, p. 815-823, 2019Tradução . . Disponível em: https://doi.org/10.1038/s41588-019-0395-x. Acesso em: 04 dez. 2025.
APA
Gusev, A., Lawrenson, K., Lin, X., Lyra Júnior, P. C., Kar, S., & Noushmehr, H. (2019). A transcriptome-wide association study of high-grade serous epithelial ovarian cancer identifies new susceptibility genes and splice variants. Nature Genetics, 51( 5), 815-823. doi:10.1038/s41588-019-0395-x
NLM
Gusev A, Lawrenson K, Lin X, Lyra Júnior PC, Kar S, Noushmehr H. A transcriptome-wide association study of high-grade serous epithelial ovarian cancer identifies new susceptibility genes and splice variants [Internet]. Nature Genetics. 2019 ; 51( 5): 815-823.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1038/s41588-019-0395-x
Vancouver
Gusev A, Lawrenson K, Lin X, Lyra Júnior PC, Kar S, Noushmehr H. A transcriptome-wide association study of high-grade serous epithelial ovarian cancer identifies new susceptibility genes and splice variants [Internet]. Nature Genetics. 2019 ; 51( 5): 815-823.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1038/s41588-019-0395-x
Trabalho de evento-resumo periodico
Serum-derived DNA methylation markers distinguish functional and invasiveness subtypes in patients harboring pituitary tumors (2019)
Castro, Ana Valéria; Wells, M.; Asmaro, K.; Sabedot, T. S.; Mosella, M. S.; Malta, T. M.; Nelson, K.; Snyder, J.; Carvalho, A. de; Noushmehr, Houtan
Fonte: Neuro-Oncology. Nome do evento: Annual Meeting European Association of Neuro-Oncology - EANO. Unidade: FMRP
Assuntos: TUMOR CARCINOIDE, GLÂNDULA PITUITÁRIA, MARCADOR MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, Ana Valéria et al. Serum-derived DNA methylation markers distinguish functional and invasiveness subtypes in patients harboring pituitary tumors. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/noz126.080. Acesso em: 04 dez. 2025. , 2019
APA
Castro, A. V., Wells, M., Asmaro, K., Sabedot, T. S., Mosella, M. S., Malta, T. M., et al. (2019). Serum-derived DNA methylation markers distinguish functional and invasiveness subtypes in patients harboring pituitary tumors. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noz126.080
NLM
Castro AV, Wells M, Asmaro K, Sabedot TS, Mosella MS, Malta TM, Nelson K, Snyder J, Carvalho A de, Noushmehr H. Serum-derived DNA methylation markers distinguish functional and invasiveness subtypes in patients harboring pituitary tumors [Internet]. Neuro-Oncology. 2019 ; 21 iii24.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1093/neuonc/noz126.080
Vancouver
Castro AV, Wells M, Asmaro K, Sabedot TS, Mosella MS, Malta TM, Nelson K, Snyder J, Carvalho A de, Noushmehr H. Serum-derived DNA methylation markers distinguish functional and invasiveness subtypes in patients harboring pituitary tumors [Internet]. Neuro-Oncology. 2019 ; 21 iii24.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1093/neuonc/noz126.080
Trabalho de evento-resumo periodico
Meningioma subgroups associated with functional genomic elements defined by DNA methylation (2019)
Malta, Tathiane Maistro; Snyder, James; Wells, Michael; Carvalho, Ana de; Poisson, Laila; Souza, Camila; Zadeh, Gelareh; Aldape, Kenneth; Tirapelli, Daniela Pretti da Cunha ; Carlotti Júnior, Carlos Gilberto ; Lee, Yan; Kalkanis, Steven; Walbert, Tobias; Noushmehr, Houtan
Fonte: Cancer Research. Nome do evento: Annual Meeting American Association for Cancer Research - AACR. Unidade: FMRP
Assuntos: MENINGIOMA, DNA, GENÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTA, Tathiane Maistro et al. Meningioma subgroups associated with functional genomic elements defined by DNA methylation. Cancer Research. Baltimore: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2019-841. Acesso em: 04 dez. 2025. , 2019
APA
Malta, T. M., Snyder, J., Wells, M., Carvalho, A. de, Poisson, L., Souza, C., et al. (2019). Meningioma subgroups associated with functional genomic elements defined by DNA methylation. Cancer Research. Baltimore: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.AM2019-841
NLM
Malta TM, Snyder J, Wells M, Carvalho A de, Poisson L, Souza C, Zadeh G, Aldape K, Tirapelli DP da C, Carlotti Júnior CG, Lee Y, Kalkanis S, Walbert T, Noushmehr H. Meningioma subgroups associated with functional genomic elements defined by DNA methylation [Internet]. Cancer Research. 2019 ; 79( 13):[citado 2025 dez. 04 ] Available from: https://doi.org/10.1158/1538-7445.AM2019-841
Vancouver
Malta TM, Snyder J, Wells M, Carvalho A de, Poisson L, Souza C, Zadeh G, Aldape K, Tirapelli DP da C, Carlotti Júnior CG, Lee Y, Kalkanis S, Walbert T, Noushmehr H. Meningioma subgroups associated with functional genomic elements defined by DNA methylation [Internet]. Cancer Research. 2019 ; 79( 13):[citado 2025 dez. 04 ] Available from: https://doi.org/10.1158/1538-7445.AM2019-841
Trabalho de evento-resumo periodico
Systematic approaches to predict oncogenic transcriptional regulatory circuitries identify important nodes in high-grade serous ovarian cancer (2019)
Abraham, Brian J.; Reddy, Jessica; Fonseca, Marcos Abraão de Souza ; Klein, Isaac A.; Afeyan, Lena K.; Corona, Rosario I.; Cejas, Paloma; Segato, Felipe; Karlan, Beth Y.; Gayther, Simon A.; Freedman, Matthew L.; Noushmehr, Houtan ; Brown, Myles; Matulonis, Ursula A.; Lawrenson, Kate; Yong, Richard A.
Fonte: Cancer Research. Nome do evento: Annual Meeting American Association for Cancer Research - AACR. Unidade: FMRP
Assuntos: NEOPLASIAS OVARIANAS, GENÉTICA MÉDICA, TUMOR CARCINOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ABRAHAM, Brian J. et al. Systematic approaches to predict oncogenic transcriptional regulatory circuitries identify important nodes in high-grade serous ovarian cancer. Cancer Research. Baltimore: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2019-2615. Acesso em: 04 dez. 2025. , 2019
APA
Abraham, B. J., Reddy, J., Fonseca, M. A. de S., Klein, I. A., Afeyan, L. K., Corona, R. I., et al. (2019). Systematic approaches to predict oncogenic transcriptional regulatory circuitries identify important nodes in high-grade serous ovarian cancer. Cancer Research. Baltimore: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.AM2019-2615
NLM
Abraham BJ, Reddy J, Fonseca MA de S, Klein IA, Afeyan LK, Corona RI, Cejas P, Segato F, Karlan BY, Gayther SA, Freedman ML, Noushmehr H, Brown M, Matulonis UA, Lawrenson K, Yong RA. Systematic approaches to predict oncogenic transcriptional regulatory circuitries identify important nodes in high-grade serous ovarian cancer [Internet]. Cancer Research. 2019 ; 79( 13): 2615.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1158/1538-7445.AM2019-2615
Vancouver
Abraham BJ, Reddy J, Fonseca MA de S, Klein IA, Afeyan LK, Corona RI, Cejas P, Segato F, Karlan BY, Gayther SA, Freedman ML, Noushmehr H, Brown M, Matulonis UA, Lawrenson K, Yong RA. Systematic approaches to predict oncogenic transcriptional regulatory circuitries identify important nodes in high-grade serous ovarian cancer [Internet]. Cancer Research. 2019 ; 79( 13): 2615.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1158/1538-7445.AM2019-2615
Trabalho de evento-resumo periodico
Non-invasive prediction of glioma tumor stemness using multimodal MRI (2019)
Davoodi-Bojd, Esmaeil; Malta, Tathiane; Griffith, Brent; Snyder, James; Walbert, Tobias; Noushmehr, Houtan ; Soltanian-Zadeh, Hamid
Fonte: Cancer Research. Nome do evento: Annual Meeting American Association for Cancer Research - AACR. Unidade: FMRP
Assuntos: GLIOMA, TUMOR CARCINOIDE, RESSONÂNCIA MAGNÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DAVOODI-BOJD, Esmaeil et al. Non-invasive prediction of glioma tumor stemness using multimodal MRI. Cancer Research. Baltimore: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2019-1939. Acesso em: 04 dez. 2025. , 2019
APA
Davoodi-Bojd, E., Malta, T., Griffith, B., Snyder, J., Walbert, T., Noushmehr, H., & Soltanian-Zadeh, H. (2019). Non-invasive prediction of glioma tumor stemness using multimodal MRI. Cancer Research. Baltimore: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.AM2019-1939
NLM
Davoodi-Bojd E, Malta T, Griffith B, Snyder J, Walbert T, Noushmehr H, Soltanian-Zadeh H. Non-invasive prediction of glioma tumor stemness using multimodal MRI [Internet]. Cancer Research. 2019 ; 79( 13): 1939.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1158/1538-7445.AM2019-1939
Vancouver
Davoodi-Bojd E, Malta T, Griffith B, Snyder J, Walbert T, Noushmehr H, Soltanian-Zadeh H. Non-invasive prediction of glioma tumor stemness using multimodal MRI [Internet]. Cancer Research. 2019 ; 79( 13): 1939.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1158/1538-7445.AM2019-1939
Trabalho de evento-resumo periodico
Pan-cancer transcription factor analyses identify ZNF217 as a novel driver in HGSOC (2019)
Nameki, Robbin; Fonseca, Marcos A. S.; Reddy, Jessica; Vavra, Kevin C.; Segato, Felipe; Corona, Rosario I.; Seo, Ji-Heui; Liu, Annie; Abbasi, Forough; Lin, Xianzhi; Karlan, Beth Y.; Freedman, Matthew L.; Gayther, Simon A.; Noushmehr, Houtan ; Lawrenson, Kate
Fonte: Clinical Cancer Research. Nome do evento: Biennial Ovarian Cancer Research Symposium. Unidade: FMRP
Assuntos: TRANSCRIÇÃO GÊNICA, NEOPLASIAS OVARIANAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NAMEKI, Robbin et al. Pan-cancer transcription factor analyses identify ZNF217 as a novel driver in HGSOC. Clinical Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 04 dez. 2025. , 2019
APA
Nameki, R., Fonseca, M. A. S., Reddy, J., Vavra, K. C., Segato, F., Corona, R. I., et al. (2019). Pan-cancer transcription factor analyses identify ZNF217 as a novel driver in HGSOC. Clinical Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Nameki R, Fonseca MAS, Reddy J, Vavra KC, Segato F, Corona RI, Seo J-H, Liu A, Abbasi F, Lin X, Karlan BY, Freedman ML, Gayther SA, Noushmehr H, Lawrenson K. Pan-cancer transcription factor analyses identify ZNF217 as a novel driver in HGSOC. Clinical Cancer Research. 2019 ; 25( 22):[citado 2025 dez. 04 ]
Vancouver
Nameki R, Fonseca MAS, Reddy J, Vavra KC, Segato F, Corona RI, Seo J-H, Liu A, Abbasi F, Lin X, Karlan BY, Freedman ML, Gayther SA, Noushmehr H, Lawrenson K. Pan-cancer transcription factor analyses identify ZNF217 as a novel driver in HGSOC. Clinical Cancer Research. 2019 ; 25( 22):[citado 2025 dez. 04 ]
Trabalho de evento-resumo periodico
DNA methylation signatures detected in a serum-based liquid biopsy distinguish functional and invasiveness features in pituitary adenomas (2019)
Wells, Michael; Sabedot, Thais Sarraf; Asmaro, Karam; Mosella, Maritza Queiroz Salas ; Malta, Tathiane; Nelson, Kevin; Snyder, James; Carvalho, Ana de; Mukherjee, Abir; Bahn, Arti; Robin, Adam; Rosenblum, Mark; Mikkelsen, Tom; Poisson, Laila; Lee, Ian; Walbert, Tobias; Kalkanis, Steven; Rock, Jack; Noushmehr, Houtan ; Chitale, Dhananjay; Castro, Anavaleria
Fonte: Neuro-oncology. Nome do evento: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Assuntos: NEOPLASIAS, GLÂNDULA PITUITÁRIA, METILAÇÃO DE DNA, MARCADOR MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WELLS, Michael et al. DNA methylation signatures detected in a serum-based liquid biopsy distinguish functional and invasiveness features in pituitary adenomas. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.426. Acesso em: 04 dez. 2025. , 2019
APA
Wells, M., Sabedot, T. S., Asmaro, K., Mosella, M. Q. S., Malta, T., Nelson, K., et al. (2019). DNA methylation signatures detected in a serum-based liquid biopsy distinguish functional and invasiveness features in pituitary adenomas. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.426
NLM
Wells M, Sabedot TS, Asmaro K, Mosella MQS, Malta T, Nelson K, Snyder J, Carvalho A de, Mukherjee A, Bahn A, Robin A, Rosenblum M, Mikkelsen T, Poisson L, Lee I, Walbert T, Kalkanis S, Rock J, Noushmehr H, Chitale D, Castro A. DNA methylation signatures detected in a serum-based liquid biopsy distinguish functional and invasiveness features in pituitary adenomas [Internet]. Neuro-oncology. 2019 ; 21 vi102.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1093/neuonc/noz175.426
Vancouver
Wells M, Sabedot TS, Asmaro K, Mosella MQS, Malta T, Nelson K, Snyder J, Carvalho A de, Mukherjee A, Bahn A, Robin A, Rosenblum M, Mikkelsen T, Poisson L, Lee I, Walbert T, Kalkanis S, Rock J, Noushmehr H, Chitale D, Castro A. DNA methylation signatures detected in a serum-based liquid biopsy distinguish functional and invasiveness features in pituitary adenomas [Internet]. Neuro-oncology. 2019 ; 21 vi102.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1093/neuonc/noz175.426
Trabalho de evento-resumo periodico
Prospective, blinded plasma based analysis for diagnosis of newly diagnosed glioma (2019)
Lee, Ian; Hunt, Rachel; Nelson, Kevin; Patil, Darshana; Datta, Vineet; Akolkar, Dadasaheb; Apurva, Sachin; Fulmali, Pooja; Puranik, Sneha; Snyder, James; Noushmehr, Houtan ; Devhare, Pradeep; Carvalho, Ana de; Datar, Rajan; Walbert, Tobias; Kalkanis, Steven
Fonte: Neuro-oncology. Nome do evento: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Assuntos: NEOPLASIAS CEREBRAIS, GLIOMA, LEUCEMIA, SEQUENCIAMENTO GENÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEE, Ian et al. Prospective, blinded plasma based analysis for diagnosis of newly diagnosed glioma. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.659. Acesso em: 04 dez. 2025. , 2019
APA
Lee, I., Hunt, R., Nelson, K., Patil, D., Datta, V., Akolkar, D., et al. (2019). Prospective, blinded plasma based analysis for diagnosis of newly diagnosed glioma. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.659
NLM
Lee I, Hunt R, Nelson K, Patil D, Datta V, Akolkar D, Apurva S, Fulmali P, Puranik S, Snyder J, Noushmehr H, Devhare P, Carvalho A de, Datar R, Walbert T, Kalkanis S. Prospective, blinded plasma based analysis for diagnosis of newly diagnosed glioma [Internet]. Neuro-oncology. 2019 ; 21 vi157–vi158.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1093/neuonc/noz175.659
Vancouver
Lee I, Hunt R, Nelson K, Patil D, Datta V, Akolkar D, Apurva S, Fulmali P, Puranik S, Snyder J, Noushmehr H, Devhare P, Carvalho A de, Datar R, Walbert T, Kalkanis S. Prospective, blinded plasma based analysis for diagnosis of newly diagnosed glioma [Internet]. Neuro-oncology. 2019 ; 21 vi157–vi158.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1093/neuonc/noz175.659
Trabalho de evento-resumo periodico
Identification of subsets of IDH-mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risks (2019)
Li, Kay Ka-Wai; Chen, Hong; Noushmehr, Houtan ; Ng, Ho-Keung
Fonte: Neuro-oncology. Nome do evento: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Assuntos: NEOPLASIAS CEREBRAIS, MUTAÇÃO GENÉTICA, ANÁLISE DE SOBREVIVÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LI, Kay Ka-Wai et al. Identification of subsets of IDH-mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risks. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.611. Acesso em: 04 dez. 2025. , 2019
APA
Li, K. K. -W., Chen, H., Noushmehr, H., & Ng, H. -K. (2019). Identification of subsets of IDH-mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risks. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.611
NLM
Li KK-W, Chen H, Noushmehr H, Ng H-K. Identification of subsets of IDH-mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risks [Internet]. Neuro-oncology. 2019 ; 21 vi146.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1093/neuonc/noz175.611
Vancouver
Li KK-W, Chen H, Noushmehr H, Ng H-K. Identification of subsets of IDH-mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risks [Internet]. Neuro-oncology. 2019 ; 21 vi146.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1093/neuonc/noz175.611
Artigo de periodico
Super-enhancer-associated LncRNA UCA1 interacts directly with AMOT to activate YAP target genes in epithelial ovarian cancer (2019)
Lin, Xianzhi ; Spindler, Tassja J.; Fonseca, Marcos Abraão de Souza ; Corona, Rosario I.; Seo, Ji-Heui; Dezem, Felipe Segato; Li, Lewyn; Lee, Janet M.; Long, Henry W.; Sellers, Thomas A.; Karlan, Beth Y.; Noushmehr, Houtan ; Freedman, Matthew L.; Gayther, Simon A.; Lawrenson, Kate
Fonte: iScience. Unidade: FMRP
Assuntos: BIOLOGIA CELULAR, NEOPLASIAS OVARIANAS, PROTEÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIN, Xianzhi et al. Super-enhancer-associated LncRNA UCA1 interacts directly with AMOT to activate YAP target genes in epithelial ovarian cancer. iScience, v. 17, p. 242-255, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.isci.2019.06.025. Acesso em: 04 dez. 2025.
APA
Lin, X., Spindler, T. J., Fonseca, M. A. de S., Corona, R. I., Seo, J. -H., Dezem, F. S., et al. (2019). Super-enhancer-associated LncRNA UCA1 interacts directly with AMOT to activate YAP target genes in epithelial ovarian cancer. iScience, 17, 242-255. doi:10.1016/j.isci.2019.06.025
NLM
Lin X, Spindler TJ, Fonseca MA de S, Corona RI, Seo J-H, Dezem FS, Li L, Lee JM, Long HW, Sellers TA, Karlan BY, Noushmehr H, Freedman ML, Gayther SA, Lawrenson K. Super-enhancer-associated LncRNA UCA1 interacts directly with AMOT to activate YAP target genes in epithelial ovarian cancer [Internet]. iScience. 2019 ; 17 242-255.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1016/j.isci.2019.06.025
Vancouver
Lin X, Spindler TJ, Fonseca MA de S, Corona RI, Seo J-H, Dezem FS, Li L, Lee JM, Long HW, Sellers TA, Karlan BY, Noushmehr H, Freedman ML, Gayther SA, Lawrenson K. Super-enhancer-associated LncRNA UCA1 interacts directly with AMOT to activate YAP target genes in epithelial ovarian cancer [Internet]. iScience. 2019 ; 17 242-255.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1016/j.isci.2019.06.025
Artigo de periodico
Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of life (2019)
Nassiri, Farshad; Price, Benjamin; Shehab, Ameer; Au, Karolyn; Cusimano, Michael D.; Jenkinson, Michael D.; Jungk, Christinde; Mansouri, Alireza; Santarius, Thomas; Suppiah, Suganth; Noushmehr, Houtan
Fonte: Neuro-oncology. Unidade: FMRP
Assuntos: MENINGIOMA, CIRURGIA, QUALIDADE DE VIDA, INSÔNIA, COGNIÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASSIRI, Farshad et al. Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of life. Neuro-oncology, v. 21, p. 32-43, 2019Tradução . . Disponível em: https://doi.org/10.1093/neuonc/noy152. Acesso em: 04 dez. 2025.
APA
Nassiri, F., Price, B., Shehab, A., Au, K., Cusimano, M. D., Jenkinson, M. D., et al. (2019). Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of life. Neuro-oncology, 21, 32-43. doi:10.1093/neuonc/noy152
NLM
Nassiri F, Price B, Shehab A, Au K, Cusimano MD, Jenkinson MD, Jungk C, Mansouri A, Santarius T, Suppiah S, Noushmehr H. Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of life [Internet]. Neuro-oncology. 2019 ; 21 32-43.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1093/neuonc/noy152
Vancouver
Nassiri F, Price B, Shehab A, Au K, Cusimano MD, Jenkinson MD, Jungk C, Mansouri A, Santarius T, Suppiah S, Noushmehr H. Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of life [Internet]. Neuro-oncology. 2019 ; 21 32-43.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1093/neuonc/noy152

Unidades USP

ReP

Filtros

Autores

Autores USP

Assuntos

Título da fonte

Nome do evento

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos